Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (ISRCTN11003996) titled 'Phase 3a and 3b update of the gastric cancer module, EORTC QLQ-STO22' on Oct. 1.
Study Type: Observational
Study Design:
Cross sectional study
Primary Sponsor: University of Southampton
Condition:
Gastric adenocarcinoma
Cancer
Intervention:
To fulfil the central objective of establishing a reliable and valid health related quality of life (HRQoL) measurement, the European Organisation for Research and Treatment of Cancer (EORTC) quality of life group (QLG) has developed a four-phase methodological framework to be used to develop domain-specific HRQoL modules in cancer (Bjordal et al. 2021). Updating modules ...